Key Takeaways

  • Abridge founder Shiv Rao navigated a challenging five-year "wilderness" period before his company achieved its current $5.3 billion valuation in vertical AI for healthcare.
  • This prolonged wait underscored the need for a "true north" thesis – an unwavering conviction about an inevitable market shift, even if the timing is unknown.
  • Survival meant extreme resilience: Rao was willing to pivot on products, features, and go-to-market strategies, but never on the core market thesis.
  • Market timing, especially in AI, is unpredictable; the ability to "just stay standing" and adapt without losing sight of the core vision is paramount.

The Five-Year Wait That Built a Billion-Dollar Business

Imagine dedicating five years to building a company, years Harry Stebbings of 20VC called a "five-year wilderness walk." Abridge founder Shiv Rao lived it. While Abridge now rides high with a $5.3 billion valuation, its journey wasn't a rocket ship from day one. Instead, it was a protracted struggle, waiting for the market—specifically, the healthcare sector's readiness for AI—to catch up with its ambitious vision.

Rao's story is a sharp counter-narrative to the “move fast and break things” mantra. He believed in a future state of the world so deeply that he spent half a decade simply trying "to not die," as he put it, until that future arrived. This period of waiting wasn't passive; it was an active fight for survival, a testament to conviction when most would have folded.

Your "True North" Thesis: The Unshakeable Conviction

What kept Abridge alive through this wilderness? For Rao, it was what he calls a "true north" thesis. “I think that certain companies, certainly ours, have to have a true north,” Rao explained. “And you you live every day in in in this anticipation that the sky is going to open up because you have this thesis about the market.”

This isn't just about having a vision. It’s about feeling in your bones that a specific, inevitable market shift is coming, even if the exact date is a mystery. For Abridge, that shift was the integration of AI into complex healthcare workflows to simplify clinician tasks. This deep-seated belief allowed Rao to endure, knowing that his fundamental bet on the future was sound, regardless of present challenges. It provided the emotional charge needed to keep pushing when external validation was scarce.

Pivot Everything But The Thesis: How to "Just Stay Standing"

Survival meant ruthless flexibility on execution. Rao was unwavering on the destination, but entirely open to changing the path. “I would have died on this hill,” he stated. “I was willing to pivot on the specific product in what specific order we'd put a feature out. I was willing to pivot on go to market... But I wasn't willing to move on the thesis.”

This distinction is crucial for founders in unpredictable markets, especially AI. It means you can abandon a product that isn't gaining traction, re-target your sales strategy, or even completely overhaul your initial offering. What you cannot abandon, if you have a true north, is the core problem you're solving or the fundamental market shift you're betting on. “You might not necessarily know exactly when it's going to come true,” Rao said, “but you know it's going to come true. And when you feel that in your bones, then you I think you you can draw a lot of resilience. You can you can you you sort of figure out that you just need to stay standing. You just need to not die.”

What to Do With This

Take five minutes this week to clearly articulate your company's "true north" thesis. What fundamental shift in the world are you betting on, and why is it inevitable? Write it down in one sentence. Then, list three ways you could pivot your current product features or go-to-market strategy without abandoning that core thesis. Pick one and test it with real users or customers this month.